From resilience to resistance: Political ecological lessons from antibiotic and pesticide resistance

Annual Review of Anthropology

Volumn 37, Issue , 2008, Pages 267-282

  Orzech, Kathryn M ^a   Nichter, Mark ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Antibiotic misuse; Global health governance; Hygiene hypothesis; Tragedy of the commons

Indexed keywords

ANTIBIOTIC RESISTANCE; HEALTH CARE; HYGIENE; PESTICIDE RESISTANCE;

ANIMALIA;

EID: 55349086588     PISSN: 00846570     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.anthro.37.081407.085205     Document Type: Article

References (114)

1. Changing prescriber behaviour: Training and treatment guidelines improve prescribing in Uganda. Essent. Drugs Monit. 28/29:15, http:// mednet2.who.int/edmonitor/edition/EDM2829en.pdf
2. Aaby P. 1995. Assumptions and contradictions in measles and measles immunization research: Is measles good for something? Soc. Sci. Med. 41:673-86
3. Abellanosa I, Nichter M. 1996. Antibiotic prophylaxis among commercial sex workers in Cebu City, Philippines: patterns of use and perceptions of efficacy. Sex. Transm. Dis. 23:407-12
4. Abramson JS, Givner LB. 1999. Bacterial resistance due to antimicrobial drug addiction among physicians. Arch. Fam. Med. 8:79-80
5. Aiello AE, Larson E. 2003. Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infect. Dis. 3:501-6
6. Akwar TH, Poppe C, Wilson J, Reid-Smith RJ, Dyck M, et al. 2007. Risk factors for antimicrobial resistance among fecal Escherichia coli from residents on forty-three swine farms. Microb. Drug Resist. 13:69-76
7. Albrich WC, Monnet DL, Harbarth S. 2004. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg. Infect. Dis. 10:514-17
8. Alliance Prudent Use Antibiot. 2005. Executive summary: global antimicrobial resistance alerts and implications. Clin. Infect. Dis. 41(Suppl. 4):S221-23
9. Anderson W. 2004. Natural histories of infectious disease: ecological vision in twentieth-century biomedical science. Osiris 19:39-61
10. Avorn J, Solomon DH. 2000. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of theraputics. Ann. Intern. Med. 133:128-35
11. Bang AT, Bang RA, Tale O, Sontakke P, Solanki J, et al. 1990. Reduction in pneumonia mortality and total childhood mortality by means of community-based intervention trial in Gadchiroli, India. Lancet 336:201-6
12. Baquero F, Campos J. 2003. The tragedy of the commons in antimicrobial chemotherapy. Rev. Esp. Quimioter. 16:11-13
13. Barrett R, Kuzawa CW, McDade T, Armelagos GJ. 1998. Emerging and re-emerging infectious diseases: the third epidemiologic transition. Annu. Rev. Anthropol. 27:247-71
14. Bavestrello L, Cabello A. 2000. How Chile tackled overuse of antimicrobials. Essent. Drugs Monit. 28/29:13-14
15. Beck U. 1996. World risk society as cosmopolitan society? Ecological questions in a framework of manufactured uncertainties. Theory Cult. Soc. 13:1-32
16. Benn CS,Melbye M, Wohlfahrt J, Bjorksten B, Aaby P. 2004. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 328:1223-27
17. Bhaskaram P. 2002. Micronutrient malnutrition, infection, and immunity: an overview. Nutr. Rev. 60:S40-45
18. Blaikie P. 1995. Understanding environmental issues. In People and Environment, ed. S Morse, M Stocking, pp. 1-30. London: UCL Press
19. Bradley RH. 2003. Child care and common communicable illnesses in children aged 37 to 54 months. Arch. Pediatr. Adolesc. Med. 157:196-200
20. Bryant RL. 1998. Power, knowledge and political ecology in the third world: a review. Prog. Phys. Geogr. 22:79-94
21. Bull JJ. 2000. Evolutionary biology: technology for the 21st century. http://www.actionbioscience.org/newfrontiers/bull.html
22. Chalker J. 2001. Improving antibiotic prescribing in Hai Phong Province, Viet Nam: the "antibiotic-dose" indicator. Bull. World Health Organ. 79:313-20
23. Cohen T, Becerra MC, Murray MB. 2004. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb. Drug Resist. 10:280-85
24. Cone RA, Martin E. 1998. Chapter 12: Corporeal flows: the immune system, global economies of food and new implications for health. In The Visible Woman: Imaging Technologies, Gender and Science, ed. PA Treichler, L Cartwright, C Penley, pp. 321-59. New York: New York Univ. Press
25. Courvalin P. 2005. Antimicrobial drug resistance: "Prediction is very difficult, especially about the filture". Emerg. Infect. Dis. 11:1503-6
26. Daigle DM, McKay GA, Wright GD. 1997. Inhibition of aminoglycoside antibiotic resistance enzymes by protein kinase inhibitors. J. Biol. Chem. 272:24755-58
27. Darwin C. 1958 [1859]. The Origin of Species by Means of Natural Selection or the Preservation ofFavoured Races in the Straggle for Life. New York: New Am. Libr. World Lit.
28. Douwes J, Pearce N. 2002. Asthma and the westernization 'package'. Int. J. Epidemiol. 31:1098-102
29. el Moussaoui R, de Borgie CA, Van Den Broek P, Hustinx WN, Bresser P, et al. 2006. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ 332:1355-58
30. Empey KM, Rapp RP, Evans ME. 2002. The effect of an antimicrobial formulary change on hospital resistance patterns. Pharmacotherapy 22:81-87
31. EMS. 2002. Fast facts: antibiotic resistance. Environmental Media Services. http://www.ems.org/antibiotics/sub2-antibiotics.html
32. Fabricant SJ, Hirschhorn N. 1987. Deranged distribution, perverse prescription, unprotected use: the irrationality of pharmaceuticals in the developing world. Health Policy Plan. 2:204-13
33. Federle MJ, Bassler BL. 2003. Interspecies; communication in bacteria. J. Clin. Invest. 112:1291-99
34. Fidler DP. 2003. Chapter 9: Antimicrobial resistance: a challenge for global health governance. In Health Impacts of Globalization: Toward Global Health Governance, ed. K Lee, pp. 144-60. New York: Palgrave MacMillan
35. Fidler DP. 2007. Reflections on the revolution in health and foreign policy. Bull. World Health Organ. 85:243-44
36. Foster KR, Grundmann H. 2006. Do we need to put society first? The potential for tragedy in antimicrobial resistance. PLoS Med. 3: e29
37. Gemplers Inc. 2008. Getting started with IPM (Integrated Pest Management). http://www.gemplers.com/tech/ipm-intro.htm
38. Gerding DN. 2000. Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect. Control Hosp. Epidemiol. 21:S12-17
39. Greenberg JB, Park TK. 1994. Political ecology. J. Polit. Ecol. 1:1-11
40. Hardin G. 1968. The tragedy of the commons. Science 162:1243-48
41. Hardt M, Negri A. 2000. Empire. Cambridge, MA: Harvard Univ. Press
42. Harrison PF, Lederberg J, eds. 1998. Antimicrobial Resistance: Issues and Options. Washington, DC: Natl. Acad. Press. 1-74 pp.
43. Hodges BM, White RL. 2001. Antimicrobial cycling: the future or a fad? Ann. Pharmacother. 35:1224-32
44. Hoffman-Goetz L. 1986. Malnutrition and immunological function with special reference to cell-mediated immunity. Yearb. Phys. Anthropol. 29:139-59
45. Holmberg SD, Solomon SL, Blake PA. 1987. Health and economic impacts of antimicrobial resistance. Rev. Infect. Dis. 9:1065-78
46. Horrigan L, Lawrence RS, Walker P. 2002. How sustainable agriculture can address the environmental and human health harms of industrial agriculture. Environ. Health Perspect. 110:445-56
47. Howard DH, Scott RD 2nd, Packard R, Jones D. 2003. The global impact of drug resistance. Clin. Infect. Dis. 36:S4-10
48. Hughes A, Reimer S, eds. 2004. Geographies of Commodity Chains. London: Routledge
49. Invasive Bact. Infect. Surveill. (IBIS) Group ICENI. 1999. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Lancet 353:1216-21
50. Kamat VR, Nichter M. 1998. Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc. Sci. Med. 47:779-94
51. Kaplan W. 2003. Effect of fixed dose combination (FDC) drugs on development of clinical antimicrobial resistance: a review paper. World Health Organization. http://www.who.int/medicinedocs/en/d/ Js6l72e/#Js6172e.11.1
52. Keep Antibiot. Work. 2001. Antibiotic resistance - an emerging public health crisis. Campaign to End Antibiotic Over-use. http:// www.keepantibioticsworking.com/library/uploadedfiles/ Antibiotic-Resistance_An_Emerging_Public_2.pdf
53. Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME. 2007. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J. Antimicrob. Chemother. 60:214-36
54. Khachatourians GG. 1998. Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria. CMAJ 159:1129-36
55. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. 2 007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-71
56. Knobler SL, Lemon SM, Najafi M, Burroughs T, eds. 2003. The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment: Workshop Summary. Washington, DC: Natl. Acad. Press
57. Krieger N. 2001. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int. J. Epidemiol. 30:668-77
58. Laxminarayan R, Brown GM. 2001. Economics of antibiotic resistance: a theory of optimal use. J. Environ. Econ. Manag. 42:183-206
59. Lemon SM. 2003. Summary and assessment. See Knobler et al. 2003, pp. 1-17
60. Levin SA. 2001. Immune systems and ecosystems. Conserv. Ecol. 5:17 http://www.consecol.org/vol5/issl/art17
61. Levy SB. 1998. Multidrug resistance - a sign of the times. N. Engl.J. Med. 338:1376-78
62. Levy SB. 2001. Antibacterial household products: cause for concern. Emerg. Infect. Dis. 7:512-15
63. Levy SB. 2003. Antibiotic resistance 1992-2002: a decade's journey. See Knobler et al. 2003, pp. 32-43
64. Lewis R. 1995. The rise of antibiotic-resistant infections. FDA Consum. Mag. Sept. http://www.fda.gov/Fdac/features/ 795-antibio.html
65. Lexchin J. 2000. Promoting resistance? Esent. Drugs Monit. 28/29:11
66. Leynaert B, Neukirch C, Jarvis D, Chinn S, Burney P, Neukirch F. 2001. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am. J. Respir. Crit. Care Med. 164:1829-34
67. Lieberman PB, Wootan MG. 1998. Protecting the Crown Jewels of Medicine: A Strategic Plan to Preserve the Effectiveness of Antibiotics. Washington, DC: Cent. Sci. Public Interest (CPSI)
68. Lipsitch M, Samore M. 2002. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg. Infect. Dis. 8:347-54
69. Luskin C. 2001. The implications of antibiotic and antiviral drug resistance for the power of Darwinian evolution. Intelligent Design and Evolution Awareness (IDEA) Club. http://www.ideacenter.org/ contentmgr/showdetails.php/id/848
70. Mabey D, Peeling RW, Ustianowski A, Perkins MD. 2004. Diagnostics for the developing world. Nat. Rev. Microbiol. 2:231-40
71. Major J, Bogwitz M, Perry T. 2003. Lone gene could force rethink on pest insect control. Presented at Int. Congr. Genet. Poster, 19th, July 6-11. Referenced in http://news.bio-medicine.org/biology-news-2/ Lone-gene-could-force-re-think-on-pest-insect-control-4295-1/
72. Martin A. 2007. FDA curbs sale of 5 seafoods farmed in China. New York Times June 29. http://www.nytimes.com/2007/06/29/business/ worldbusiness/29fish.html
73. Martin G. 2006. The global health governance of antimicrobial effectiveness. Glob. Health 2:7, http://www. globalizationandhealth.com/content/2/1/7
74. Martinez JL, Baquero F. 2000. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44:1771-77
75. Mayr E. 2001. What Evolution Is. New York: Basic Books. 318 pp.
76. Maziak W. 2005. The asthma epidemic and our artificial habitats. BMC Pulm. Med. 5:5-11
77. McDade TW, Worthman CM. 1999. Evolutionary process and the ecology of human immune function. Am. J. Human Biol. 11:705-17
78. McManus PS. 1999. Antibiotic use in plant disease control. APUA Newsl. 17:1-3
79. Mellor S. 2004. Dairy cattle: alternatives to antibiotics. Community of International Business Related to Animal Production. http://www.engormix.com
80. Morse SS. 1995. Factors in the emergence of infectious diseases. Emerg. Infect. Dis. 1:7-15
81. Nichter M. 2001. Vulnerability, prophylactic antibiotic use, harm reduction and the misguided appropriation of medical resources: the case of STDs in Southeast Asia. In Culture and Reproductive Health, ed. C Obermeyer, pp. 101-27. Oxford, UK: Oxford Univ. Press
82. Nichter M. 2008. Global Health: Why Cultural Perceptions, Social Representations and Biopolitics matter. Tucson: Univ. Ariz. Press
83. Nichter M, Vuckovic N. 1994. Agenda for an anthropology of pharmaceutical practice. Soc. Sci. Med. 39:1509-25
84. Nizami SQ, Khan IA, Bhutta ZA. 1997. Paediatric prescribing in Karachi. J. Pak. Med. Assoc. 47:29-32
85. Okeke IN, Lamikanra A, Edelman R. 1999. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg. Infect. Dis. 5:18-27
86. Okumura J, Wakai S, Umenai T. 2002. Drug utilisation and self-medication in rural communities in Vietnam. Soc. Sci. Med. 54:1875-86
87. Pang T, Guindon GE. 2004. Globalization and risks to health. EMBO Rep. 5:S11-16
88. Paredes P, de la Pena M, Flores-Guerra E, Diaz J, Trostle J. 1996. Factors influencing physicians' prescribing behaviour in the treatmentof childhood diarrhoea: knowledge may not be the clue. Soc. Sci. Med. 42:1141-53
89. Peterson G. 2000. Political ecology and ecological resiliance: an integration of human and ecological dynamics. Ecol. Econ. 35:323-36
90. Price DB, Honeybourne D, Little P, Mayon-White RT, Read RC, et al. 2004. Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice. Respir. Med. 98:17-24
91. Radyowijati A, Haak H. 2003. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc. Sci. Med. 57:733-44
92. Rietveld RP, Bindels PJ, ter Riet G. 2006. Antibiotics for upper respiratory tract infections and conjunctivitis in primary care. BMJ 333:311-12
93. Saradamma RD, Higgenbothan N, Nichter M. 2000. Social factors influencing the acquisition of antibiotics without a prescription in Kerala State, South India. Soc. Sci. Med. 50:891-903
94. Schentag JJ. 2001. Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit. Crit. Care Med. 29:N100-7
95. Siegel RM, Kiely M, Bien JP, Joseph EC, Davis JB, et al. 2003. Treatment of otitis media with observation and a safety-net antibiotic prescription. Pediatrics 112:527-31
96. Simon A, Janabi M, Kalmayem G, Waidubu G, Galia E, et al. 1996. Caretakers' management of childhood acute respiratory infections and the use of antibiotics, Bohol, the Philippines. Hum. Organ. 55:76-83
97. Simonsen GS, Tapsall JW, Allegranzi B, Talbot EA, Lazzari S. 2004. The antimicrobial resistance containment and surveillance approach - a public health tool. Bull. World Health Organ. 82:928-34
98. Simpson SA, Wood F, Butler CC. 2007. General practitioners' perceptions of antimicrobial resistance: a qualitative study. J. Antimicrob. Chemother. 59:292-96
99. Sipress A. 2005, Human drug used on China chickens; antiviral employed to fight bird flu. Washington Post June 18:A1
100. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. 2004. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis. 38:1279-86
101. Strachan DP. 1989. Hay fever, hygiene, and household size. BMJ 299:1259-60
102. Strachan DP. 1999. Lifestyle and atopy. Lancet 353:1457-58
103. Stratchounski LS, Andreeva IV, Ratchina SA, Galkin DV, Petrotchenkova NA, et al. 2003. The inventory of antibiotics in Russian home medicine cabinets. Clin. Infect. Dis. 37:498-505
104. Tan L, Nielsen NH, Young DC, Trizna Z. 2002. Use of antimicrobial agents in consumer products. Arch. Dermatol. 138:1082-86
105. Thomas K, Lalitha MK, Steinhoff MC, Ganesan A. 2003. Temporal trends in antimicrobial resistance patterns of invasive pnuemococci in 7 hospitals in India - a 10 year experience. Presented at Intersci. Conf. Antimicrob. Agents Chemother.
106. Thomke S, Elwinger K. 1997. Report to the Commission on Antimicrobial Feed Additives. Uppsala: Swedish Univ. Agric.
107. Tierno P. 2001. The Secret Life of Germs. New York: Simon and Schuster
108. UCS. 2003. Antibiotic resistance program update. Union of Concerned Scientists. http://www.ucsusa.org/food_and_environment/ antibiotics_and_food/
109. Van Der Geest S. 1987. Self-care and the informal sale of drugs in south Cameroon. Soc. Sci. Med. 25:293-305
110. Waters CM, Bassler BL. 2005. Quorum sensing: cell-to-cell communication in bacteria. Annu. Rev. Cell Dev. Biol. 21:319-46
111. Wegener HC. 2005. The food chain: antibiotic use in animals. Wellcome Trust. http://www.wellcome.ac.uk/stellent/groups/ corporatesite/μsh_publishing_group/documents/web_document/ wtx026231.pdf
112. WHO. 1999. Containing antimicrobial resistance: review of the literature and report of a WHO workshop on the development of a global strategy for the containment of antimicrobial resistance. WHO/CDS/CSR/DRS/99/2, World Health Organization, Geneva
113. WHO. 2001. Executive summary: WHO global strategy for containment of antimicrobial resistance. WHO/CDS/CSR/DRS/2001/2/EN, World Health Organization, Geneva
114. Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. 2006. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2:6-19